Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,363 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease: A Secondary Analysis of DANFLU-1.
Bartholdy KV, Johansen ND, Janstrup KH, Modin D, Nealon J, Samson S, Loiacono MM, Harris R, Schade Larsen C, Reimer Jensen AM, Emanuel Landler N, Claggett BL, Solomon SD, Landray MJ, Gislason GH, Hansen D, Køber L, Sivapalan P, Vestergaard LS, Jensen JUS, Biering-Sørensen T. Bartholdy KV, et al. Among authors: solomon sd. J Am Coll Cardiol. 2024 Aug 13:S0735-1097(24)08018-5. doi: 10.1016/j.jacc.2024.07.032. Online ahead of print. J Am Coll Cardiol. 2024. PMID: 39217544 No abstract available.
Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes.
Neuen BL, Ostrominski JW, Claggett B, Beldhuis IE, Chatur S, McCausland FR, Badve SV, Arnott C, Heerspink HJL, Jun M, Falster M, de Oliveira Costa J, Pollock C, Jardine MJ, Mahaffey KW, Perkovic V, Solomon SD, Vaduganathan M. Neuen BL, et al. Among authors: solomon sd. J Am Coll Cardiol. 2024 Nov 26;84(22):2246-2250. doi: 10.1016/j.jacc.2024.08.006. Epub 2024 Aug 31. J Am Coll Cardiol. 2024. PMID: 39217558 No abstract available.
Stratifying Disease Progression in Patients With Cardiac ATTR Amyloidosis.
Ioannou A, Cappelli F, Emdin M, Nitsche C, Longhi S, Masri A, Cipriani A, Zampieri M, Colio F, Poledniczek M, Porcari A, Razvi Y, Aimo A, Vergaro G, De Michieli L, Rauf MU, Patel RK, Villanueva E, Lustig Y, Venneri L, Martinez-Naharro A, Lachmann H, Wechalekar A, Whelan C, Petrie A, Hawkins PN, Solomon S, Gillmore JD, Fontana M. Ioannou A, et al. J Am Coll Cardiol. 2024 Mar 1;83(14):1276-91. doi: 10.1016/j.jacc.2023.12.036. Online ahead of print. J Am Coll Cardiol. 2024. PMID: 38530684 Free PMC article.
Prognostic Value of a 6-Minute Walk Test in Patients With Transthyretin Cardiac Amyloidosis.
Ioannou A, Fumagalli C, Razvi Y, Porcari A, Rauf MU, Martinez-Naharro A, Venneri L, Moody W, Steeds RP, Petrie A, Whelan C, Wechalekar A, Lachmann H, Hawkins PN, Solomon SD, Gillmore JD, Fontana M. Ioannou A, et al. Among authors: solomon sd. J Am Coll Cardiol. 2024 Jul 2;84(1):43-58. doi: 10.1016/j.jacc.2024.04.011. Epub 2024 May 13. J Am Coll Cardiol. 2024. PMID: 38739065 Free PMC article.
Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial.
Gheorghiade M, Greene SJ, Butler J, Filippatos G, Lam CS, Maggioni AP, Ponikowski P, Shah SJ, Solomon SD, Kraigher-Krainer E, Samano ET, Müller K, Roessig L, Pieske B; SOCRATES-REDUCED Investigators and Coordinators. Gheorghiade M, et al. Among authors: solomon sd. JAMA. 2015 Dec 1;314(21):2251-62. doi: 10.1001/jama.2015.15734. JAMA. 2015. PMID: 26547357 Clinical Trial.
Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant-level pooled analysis of the CANVAS and CREDENCE trials.
Chatur S, Vaduganathan M, Fletcher RA, Perkovic V, Heerspink H, Arnott C, Pollock C, Mahaffey KW, Neal B, Jardine M, Solomon SD, Neuen BL. Chatur S, et al. Among authors: solomon sd. Eur J Heart Fail. 2025 Jan 23. doi: 10.1002/ejhf.3586. Online ahead of print. Eur J Heart Fail. 2025. PMID: 39844714
Clinical Phenotype and Prognosis of Asymptomatic Patients With Transthyretin Cardiac Amyloid Infiltration.
Porcari A, Razvi Y, Cappelli F, Nitsche C, Serenelli M, Longhi S, Sinigiani G, Cipriani A, Aimo A, Tomasoni D, Zampieri M, Cantone A, Allegro V, Vergaro G, Masri A, Urey M, Ioannou A, Petrie A, Noory N, Gustafsson F, Poledniczek M, Emdin M, Metra M, Sinagra G, Martinez-Naharro A, Wechalekar AD, Lachman H, Whelan C, Hawkins PN, Solomon SD, Gillmore JD, Fontana M. Porcari A, et al. Among authors: solomon sd. JAMA Cardiol. 2025 Jan 22. doi: 10.1001/jamacardio.2024.5221. Online ahead of print. JAMA Cardiol. 2025. PMID: 39841451
Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial.
Butt JH, Jhund PS, Henderson AD, Claggett BL, Desai AS, Viswanathan P, Kolkhof P, Schloemer P, Amarante F, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Vaduganathan M, Solomon SD, McMurray JJV; FINEARTS-HF Committees and Investigators. Butt JH, et al. Among authors: solomon sd. Lancet Diabetes Endocrinol. 2025 Jan 13:S2213-8587(24)00309-7. doi: 10.1016/S2213-8587(24)00309-7. Online ahead of print. Lancet Diabetes Endocrinol. 2025. PMID: 39818225 Free article.
1,363 results